Smartlife forging ahead with health product

Smartlifeinc Limited - Wellwatch Project – a project co-funded by the Horizon 2020 Programme of the European Commission under Grant Agreement No. 740980.

WW Logo.png

September 2016: Smartlifeinc Ltd applied for Phase 1 H2020 SME funding under the Open Disruptive Innovation Scheme Topic in 2016. In total 1,938 applications were submitted in the September call with 189 small and medium-sized enterprises (SMEs) from 24 countries selected for funding.

Read more about the Horizon2020 SME Instrument here: http://bit.ly/2fZj4wL

November 2016: The 189 SMEs who received funds proposed 182 projects in total (multiple SMEs can be involved in one project). With total funding at € 9.1 million for this cut-off.  Smartlifeinc was one of only 18 UK companies funded under this call for its Wellwatch project.

July 2017: The Wellwatch project was reviewed by the EC and this first stage project successfully concluded.  The invaluable assistance received by the EC has meant that this ground-breaking innovative medical device can now progress further in development.

View the Wellwatch project on CORDIS (the European Commission's primary portal for results of EU-funded research projects): http://bit.ly/2y7pdSm